| Biomarker ID | 814 |
| PMID | 22113713 |
| Year | 2012 |
| Biomarker | (IL-7) Interleukin-7 |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Associated with Prostate cancer specific Survival |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: 0.1 (95% CI: 0.02–0.86) |
| Effect on Pathways | Pathways Include:-Cytokines and inflammatory response, Hematopoiesis regulation by cytokines, Interleukin-7 signaling pathway,Hematopoietic cell lineage,Signaling by interleukins |
| Experiment | disease specific survival Vs no survival |
| Type of Biomarker | Prognostic |
| Cohort | 44 patients with prostate cancer who ubderwent radical prosteactomy were chosen for the study. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.03 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | Multivariate model considering Gleason Score, PSA, TGFb1 and IL-7. log-transformed expressions were used |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | IL7 |